Work

Randomized, double-blind phase II study of anti-endotoxin antibody (E5) as adjuvant therapy in humans with serious gram-negative infections.

Year: 1991

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: PubMed

Authors: R N Greenberg, K M Wilson, A Y Kunz, N I Wedel, K J Gorelick

Institution: Saint Louis University

Language: English

Topic: Sepsis Diagnosis and Treatment

Subfield: Critical Care and Intensive Care Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2416189220

FWCI:

Cites:

Cited by: 12

Related to: 10